Yasamin Dabiri
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade.
Journal: Gut
Published: May 21, 2022
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins.
Journal: JACS Au
Published: January 06, 2021
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling.
Journal: The Journal of cell biology
Published: December 19, 2020
Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.
Journal: Nature
Published: November 25, 2019
p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells.
Journal: Frontiers in oncology
Published: February 21, 2019
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway.
Journal: International journal of molecular sciences
Published: November 27, 2018
Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics.
Journal: Cancer & metabolism
Published: July 13, 2018
Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Journal: European journal of medicinal chemistry
Published: February 15, 2018
Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Journal: Molecular carcinogenesis
Published: March 25, 2017
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
Journal: Scientific reports
Published: February 16, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026